Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Osteopore Ltd. ( (AU:OSX) ) has provided an announcement.
Osteopore Limited has announced a further drawdown of its Tranche 1 redeemable convertible notes, raising an additional A$250,000. This funding, part of a larger A$20 million subscription agreement with Advance Opportunities Fund, will support the company’s ongoing business operations and future development projects. The strategic financial move is expected to bolster Osteopore’s market positioning and facilitate the advancement of its innovative regenerative medicine solutions.
More about Osteopore Ltd.
Osteopore Limited is a Singapore-founded regenerative medicine company and a global leader in 3D-printed biomimetic and bioresorbable implants. The company focuses on commercializing products that stimulate natural bone healing across multiple segments. Osteopore’s patented scaffolds, made from naturally dissolving polymers, guide and nurture bone-forming cells, significantly reducing post-surgery complications associated with permanent bone implants.
Average Trading Volume: 1,502,014
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.3M
See more data about OSX stock on TipRanks’ Stock Analysis page.